CME Launches Single Stock Futures, Aligning Stock Futures with Commodities

TL;DR · CME has launched cash-settled single stock futures, covering underlying assets such as Nvidia, Tesla, Apple, Micron, and SPCX. · Low margin, nearly 23 hours of trading, and linear profit and loss fill the gap between stocks and options. · Related assets: CME, NVDA, TSLA, AAPL, MU, SPCX, AMZN, META.

CME launched single stock futures on July 27, initially including 55 standard contracts and 22 micro contracts, covering over 50 U.S. stocks, including Nvidia, Tesla, Apple, Amazon, Meta, Micron, and SPCX.

For investors, it provides a new way to express directional views. Betting on the rise and fall of popular U.S. stocks no longer requires buying stocks, purchasing options, or seeking synthetic exposure in other markets. CME integrates single stocks into the futures framework, allowing investors to trade directions with lower margins over longer periods.

Single stock futures are not a new product. The U.S. market attempted this over twenty years ago, with OneChicago eventually closing in 2020. CME's restart tests whether single stock futures can regain liquidity in the U.S. after retail derivatives have matured and micro contracts have become more widespread.

Futures Version of Stock Direction Trading

Single stock futures can be understood as the futures version of stock direction trading. Investors do not need to actually buy or borrow stocks, and there is no delivery of stocks at expiration; instead, they settle in cash. If the underlying rises, the long contract profits; if it falls, the short contract profits.

The biggest difference from spot stocks is capital efficiency. CME's FAQ indicates that due to CFTC and SEC regulatory requirements, the initial and maintenance margin for both long and short positions is at least 15% of the current nominal value. Actual broker or clearing margins may be higher, but this threshold is still lower than the common requirements for regular stock margin accounts.

Low margin does not equate to low risk; it only represents higher leverage. When the underlying moves in the opposite direction, losses are calculated based on the full nominal exposure, which may exceed the initial margin. For traders accustomed to crypto perpetual contracts, this logic is familiar; for beginners who only buy stocks, understanding leverage is the most critical risk to grasp first.

The difference from options lies in the more linear profit and loss. Options involve time value, volatility, strike price, and Greeks, and even if the directional judgment is correct, one may still lose money due to time decay. The profit and loss of single stock futures are closer to the stocks themselves, making them more suitable for expressing simple directional views or hedging.

Another change is the trading hours. CME single stock futures trade on Globex from Sunday to Friday, with trading hours from 5 PM to 4 PM Central Time the next day, with a daily maintenance period of 1 hour, totaling nearly 23 hours. This covers more Asian, European, and U.S. post-market news windows.

CME Bets on Market Structure Changes

Tim McCourt, CME's Global Head of Equities, FX, and Alternative Products, stated in the announcement that clients want to manage individual stock price risks more precisely while leveraging centralized clearing to improve capital efficiency. CME's goal is not just to increase speculative tools but also to extend trading habits from index futures to single stocks.

This logic holds because CME already has a mature user base for index futures, a market maker system, and a clearing network. Institutions can combine broad-based index futures with single stock futures for finer risk adjustments; active retail users can use micro contracts to lower entry barriers.

The standard contract multiplier is 100 shares, while the micro contract is 10 shares. For popular tech stocks, micro contracts are more suitable for users with smaller account sizes who still want to trade directional exposure. Today's retail traders are also more familiar with options, futures, perpetual contracts, and post-market volatility.

CME Chairman and CEO Terry Duffy does not shy away from historical failures. According to media reports, he mentioned in a conference call that early attempts at single stock futures were a "complete failure," but since 2000, technology, market structure, and investor demand have changed significantly. This judgment is a prerequisite for the success of this round of products.

It will not replace options; rather, it serves as a third tool between stocks and options. It is more capital-efficient than spot trading, more linear than options, and more standardized than some over-the-counter or on-chain synthetic assets.

SPCX as a Trending Asset and Stress Test

Among this batch of contracts, SPCX is one of the most talked-about assets. CME SER documents specify Space Exploration Technologies Corp Stock Futures, with the standard contract code SSPCX and the micro contract code TSPCX. SpaceX is set to list on the Nasdaq Global Select Market and Nasdaq Texas on June 12, 2026, with the stock code SPCX.

The highlight of SPCX is not the "inability to buy the spot," but rather its short listing time, high attention, and strong volatility expectations, leading investors to have a concentrated demand for off-exchange trading, short selling, and derivative exposure. Single stock futures provide a more direct directional tool for such assets, eliminating the need to deal with borrowing stocks, physical delivery, or complex options structures.

It also serves as a mechanism stress test. For highly liquid stocks like Nvidia, Tesla, and Apple, futures prices are more likely to form around spot prices. For assets with short listing times and high attention, investors need to observe whether the settlement reference, intraday quotes, bid-ask spreads, and market depth remain stable.

CME's cash settlement framework relies on a clear price basis for the underlying asset. The FAQ indicates that the final settlement price at expiration uses the official closing price of the underlying on the primary listing exchange. The rules address the expiration pricing issue, but traders are more concerned about whether there are continuous quotes during the day and whether spreads will suddenly widen during news periods.

Liquidity Determines Tool Value

The biggest enemy of single stock futures is not product design but liquidity self-bootstrapping. Traders need narrow spreads to be willing to enter the market, and market makers need active traders to be willing to provide quotes. Once this cycle starts, the product will become increasingly useful; if it fails to start, low margins and long durations will also struggle to retain users.

The lesson from OneChicago lies here. Single stock futures do not lack theoretical applications, but if trading volume is low, education costs are high, and broker promotion is weak, it is difficult to become a mainstream trading tool. CME has a stronger platform, a more mature clearing network, and more retail access this time, but these can only improve the probability of success, not replace actual trading.

Risks must also be viewed on the same chart. Price fluctuations after hours and following major news can be amplified during low liquidity periods; with lower margins, investors are more likely to underestimate the speed of losses from full exposure. The futures interface improves trading efficiency but also amplifies the feedback speed of erroneous positions.

The more reasonable positioning of this round of single stock futures is that CME has added a new interface for popular U.S. stocks and SPCX. Its specifications are clear: minimum margin of at least 15%, nearly round-the-clock trading, linear profit and loss, and centralized clearing. Its success or failure will still need to be validated by trading data.

The trading volume, open interest, bid-ask spreads, and market depth in the first month after launch will be more indicative than the product announcement. If contracts for Nvidia, Tesla, SPCX, etc., form stable liquidity, it will become a new addition to the toolbox for trading tech stocks; if orders remain in the trial phase, U.S. single stock futures will still return to the old problem: the tool is useful, but no one uses it.